Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies
The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation o...
Saved in:
| Published in | PloS one Vol. 14; no. 4; p. e0216065 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article Web Resource |
| Language | English |
| Published |
United States
Public Library of Science
29.04.2019
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies.
Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors.
A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire.
This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score". |
|---|---|
| AbstractList | ObjectivesThe Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies.MethodsSubjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors.ResultsA total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire.ConclusionThis study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score". Objectives The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. Methods Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. Results A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. Conclusion This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical “true score”. The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score". The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by [square root]2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score". Objectives The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. Methods Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. Results A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. Conclusion This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical “true score”. The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies.OBJECTIVESThe Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies.Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors.METHODSSubjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by √2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors.A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire.RESULTSA total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire.This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score".CONCLUSIONThis study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score". Objectives The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient- reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. Methods Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the dif- ference between test and retest scores (SDdiff) by p2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. Results A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the indi- vidual studies, and was 2.65 points when all subjects were analyzed together. The SDC forhe overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. Conclusion This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical “true score”. Objectives The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It produces 7 domain scores and 1 overall quality of life score, all between 0 and 100 points. This study aims to contribute to the interpretation of the SarQoL scores by calculating the standard error of measurement (SEM) and smallest detectable change (SDC) in a sample of subjects from 9 studies. Methods Subjects from 9 studies (conducted in Belgium, Brazil, Czech Republic, England, Greece, Lithuania, Poland and Spain) were included. The SEM, a measure of the error in the scores that is not due to true changes, was calculated by dividing the standard deviation of the difference between test and retest scores (SDdiff) by [square root]2. The SDC, defined as change beyond measurement error, was calculated by multiplying SDdiff by 1.96. Bland-Altman plots were assessed for the presence of systematic errors. Results A total of 278 sarcopenic subjects, aged 77.67 ± 7.64 years and 61.5% women, were included. The SEM for the overall SarQoL score ranged from 0.18 to 4.20 points for the individual studies, and was 2.65 points when all subjects were analyzed together. The SDC for the overall score ranged from 0.49 to 11.65 points for the individual studies, and was 7.35 points for all subjects. The Bland-Altman plots revealed no systematic errors in the questionnaire. Conclusion This study shows that, for individual subjects, a change in overall quality of life of at least 7.35 points (on a scale from 0 to 100) would have to be observed to confirm that a true change, beyond measurement error, has occurred. It also demonstrated that the SarQoL questionnaire is a precise instrument, with the observed scores within less than 3 points of the theoretical "true score". |
| Audience | Academic |
| Author | De Souza Orlandi, Fabiana Bautmans, Ivan Cooper, Cyrus Beaudart, Charlotte Geerinck, Anton Topinková, Eva Tsekoura, Maria Konstantynowicz, Jerzy Bruyère, Olivier Reginster, Jean-Yves Montero-Errasquín, Beatriz Alekna, Vidmantas |
| AuthorAffiliation | 3 Frailty in Aging Research Group, Vrije Universiteit Brussel, Brussels, Belgium 6 Department of Pediatric Rheumatology, Immunology and Metabolic Bone Diseases, Medical University of Bialystok, Bialystok, Poland 5 Department of Gerontology, Federal University of São Carlos, São Carlos, SP, Brazil 7 Department of Geriatrics, University Hospital Ramón y Cajal, Madrid, Spain 9 Department of Physical Therapy, School of Health and Welfare, Technological Institute of Western Greece, Aigio, Greece 4 MRC Environmental Epidemiology Unit, Southampton General Hospital, Southampton, United Kingdom 8 Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic 2 Faculty of Medicine, Vilnius University, Vilnius, Lithuania Iranian Institute for Health Sciences Research, ISLAMIC REPUBLIC OF IRAN 1 World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Department of Public Health, Epidemiology and Health Eco |
| AuthorAffiliation_xml | – name: Iranian Institute for Health Sciences Research, ISLAMIC REPUBLIC OF IRAN – name: 7 Department of Geriatrics, University Hospital Ramón y Cajal, Madrid, Spain – name: 9 Department of Physical Therapy, School of Health and Welfare, Technological Institute of Western Greece, Aigio, Greece – name: 3 Frailty in Aging Research Group, Vrije Universiteit Brussel, Brussels, Belgium – name: 4 MRC Environmental Epidemiology Unit, Southampton General Hospital, Southampton, United Kingdom – name: 5 Department of Gerontology, Federal University of São Carlos, São Carlos, SP, Brazil – name: 2 Faculty of Medicine, Vilnius University, Vilnius, Lithuania – name: 8 Department of Geriatrics and Gerontology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic – name: 6 Department of Pediatric Rheumatology, Immunology and Metabolic Bone Diseases, Medical University of Bialystok, Bialystok, Poland – name: 1 World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing, Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium |
| Author_xml | – sequence: 1 givenname: Anton orcidid: 0000-0002-1669-0224 surname: Geerinck fullname: Geerinck, Anton – sequence: 2 givenname: Vidmantas surname: Alekna fullname: Alekna, Vidmantas – sequence: 3 givenname: Charlotte surname: Beaudart fullname: Beaudart, Charlotte – sequence: 4 givenname: Ivan surname: Bautmans fullname: Bautmans, Ivan – sequence: 5 givenname: Cyrus surname: Cooper fullname: Cooper, Cyrus – sequence: 6 givenname: Fabiana surname: De Souza Orlandi fullname: De Souza Orlandi, Fabiana – sequence: 7 givenname: Jerzy surname: Konstantynowicz fullname: Konstantynowicz, Jerzy – sequence: 8 givenname: Beatriz surname: Montero-Errasquín fullname: Montero-Errasquín, Beatriz – sequence: 9 givenname: Eva surname: Topinková fullname: Topinková, Eva – sequence: 10 givenname: Maria surname: Tsekoura fullname: Tsekoura, Maria – sequence: 11 givenname: Jean-Yves surname: Reginster fullname: Reginster, Jean-Yves – sequence: 12 givenname: Olivier surname: Bruyère fullname: Bruyère, Olivier |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31034498$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9k9tq3DAQhk1JaQ7tG5RW0Jv0YreSZct2Lgoh9BBYKCHttRjLo40WWdpKdmDfqI9ZeXdTsiEUX0jMfPPPwZrT7Mh5h1n2ltE54xX7tPJjcGDn62Se05wJKsoX2QlreD4TOeVHj-7H2WmMK0pLXgvxKjvmjPKiaOqT7M_tAK6D0BEMwQfiNekR4hiwRzeQ5COxB2sxDqTDAdUArUWi7sAtcaKHOyS3EJRfozNAbkawZthMnoXRSM6T78YvPpLfY5Iw3jkwAS_IpUvaYDfRxImNY7tK2pHo4HvSkPuk0sHEkziMncH4OnupwUZ8sz_Psl9fv_y8-j5b_Ph2fXW5mKmK8mEmCtoKpgTX0LYKWt1iU3Vt02ktBMsV6LJljOqi7kQHilZClFo3wIoGSqhafpa93-murY9yP-Qo85xVtMkbQRNxvSM6Dyu5DqaHsJEejNwafFhKCINRFiUDxZTiAnWtCqEKqLmgqlaU86YSXZ20Pu-zjW2PnUozD2APRA89ztzJpb-XoqhrWjdJgO8ErMElpuStkff5NnB7H22qRskWUweiljkvmrxMUef7tMFvf4zsTVRoLTj0467bItVasoR-eII-P5M9tYTUtnHap2rVJCovy5o3ZS621PwZKn0d9kald6xNsh8EvHs8nn9zeXi_CbjYASr4GANqqcywfTdJ2VjJqJyW5aFmOS2L3C9LCi6eBD_o_zfsL0P7Heg |
| CitedBy_id | crossref_primary_10_1186_s12955_023_02147_5 crossref_primary_10_1007_s40520_020_01780_0 crossref_primary_10_3390_ijerph19084561 crossref_primary_10_1016_j_mad_2024_112002 crossref_primary_10_1002_msc_1607 crossref_primary_10_1007_s40520_023_02438_3 crossref_primary_10_2196_55324 crossref_primary_10_1177_01461672221133693 crossref_primary_10_3389_fpsyg_2023_1225850 crossref_primary_10_1007_s11136_021_02823_3 crossref_primary_10_2147_JPR_S430280 crossref_primary_10_3390_jcm11247509 crossref_primary_10_1016_j_jht_2024_12_002 crossref_primary_10_1111_ejn_16187 crossref_primary_10_3390_jcm9020441 crossref_primary_10_3390_jcm10214887 crossref_primary_10_1007_s40520_025_02995_9 crossref_primary_10_1186_s12877_022_03077_5 crossref_primary_10_1007_s40520_020_01663_4 crossref_primary_10_1080_09638288_2024_2337107 crossref_primary_10_1016_j_bjps_2024_06_002 crossref_primary_10_3390_app10238558 crossref_primary_10_1016_j_tjfa_2024_100010 crossref_primary_10_1016_j_ctim_2020_102492 crossref_primary_10_1016_j_msksp_2020_102134 crossref_primary_10_3389_fpsyg_2023_1207199 crossref_primary_10_2490_prm_20210051 crossref_primary_10_3390_healthcare12050557 crossref_primary_10_14283_jfa_2021_53 crossref_primary_10_1186_s12955_024_02257_8 crossref_primary_10_1016_j_msksp_2020_102315 crossref_primary_10_1002_pmrj_12863 crossref_primary_10_1007_s40520_021_01913_z crossref_primary_10_1186_s12891_024_07752_z crossref_primary_10_1002_jcsm_12687 crossref_primary_10_1002_pri_2016 crossref_primary_10_1016_j_burns_2024_107359 crossref_primary_10_3389_fpsyg_2024_1494261 crossref_primary_10_1136_bjsports_2022_106347 |
| Cites_doi | 10.3390/jcm7100323 10.1371/journal.pone.0169548 10.1016/j.msksp.2017.08.007 10.1016/j.jclinepi.2014.01.003 10.1093/ajcn/72.3.796 10.1016/j.jclinepi.2006.03.012 10.1080/09638288.2018.1514076 10.1007/s40520-017-0866-9 10.1007/s40520-015-0517-y 10.1007/s00223-016-0220-9 10.1111/j.1745-3992.1991.tb00195.x 10.1016/S0140-6736(86)90837-8 10.1093/ageing/afv133 10.1017/CBO9780511996214 10.1016/j.jclinepi.2016.03.015 10.1007/s11136-014-0632-9 10.1186/s40200-017-0302-x 10.1002/jcsm.12149 10.1186/1477-7525-6-55 10.1590/bjpt-rbf.2014.0045 10.1007/s11657-017-0397-1 10.2519/jospt.2003.33.12.734 |
| ContentType | Journal Article Web Resource |
| Copyright | COPYRIGHT 2019 Public Library of Science 2019 Geerinck et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019 Geerinck et al 2019 Geerinck et al |
| Copyright_xml | – notice: COPYRIGHT 2019 Public Library of Science – notice: 2019 Geerinck et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019 Geerinck et al 2019 Geerinck et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 Q33 5PM DOA |
| DOI | 10.1371/journal.pone.0216065 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database (ProQuest) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database ProQuest Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (ProQuest) Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic Université de Liège - Open Repository and Bibliography (ORBI) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Agricultural Science Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Medicine Public Health |
| DocumentTitleAlternate | Standard error of measurement and smallest detectable change of the SarQoL questionnaire |
| EISSN | 1932-6203 |
| ExternalDocumentID | 2217092960 oai_doaj_org_article_1ac1cc36ef8c46c4a8360c8c033976d8 PMC6488089 oai_orbi_ulg_ac_be_2268_234925 A583952660 31034498 10_1371_journal_pone_0216065 |
| Genre | Validation Study Journal Article |
| GeographicLocations | Greece Belgium |
| GeographicLocations_xml | – name: Greece – name: Belgium |
| GrantInformation_xml | – fundername: Medical Research Council grantid: G0400491 – fundername: Medical Research Council grantid: MC_UU_12011/1 – fundername: Medical Research Council grantid: MC_U147585824 – fundername: Medical Research Council grantid: MC_UP_A620_1014 – fundername: Medical Research Council grantid: MC_U147585819 – fundername: ; grantid: FC29883 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM ADRAZ CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB RIG BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 Q33 5PM PUEGO - 02 AAPBV ABPTK BBAFP KM |
| ID | FETCH-LOGICAL-c703t-640b61c63fabbcabfbe97db9dff6612caf5b110f48d6dac07665ff9a149a5a7b3 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun Sep 04 00:10:39 EDT 2022 Wed Aug 27 01:29:10 EDT 2025 Thu Aug 21 18:30:41 EDT 2025 Fri Jul 25 15:36:08 EDT 2025 Fri Jul 11 02:55:20 EDT 2025 Sat Aug 23 13:07:59 EDT 2025 Tue Jun 17 20:39:12 EDT 2025 Tue Jun 10 20:42:37 EDT 2025 Mon Jul 21 06:02:45 EDT 2025 Tue Jul 01 01:09:48 EDT 2025 Thu Apr 24 23:06:43 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c703t-640b61c63fabbcabfbe97db9dff6612caf5b110f48d6dac07665ff9a149a5a7b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 scopus-id:2-s2.0-85065447851 Competing Interests: AG is supported by a FRIA fellowship grant from the F.R.S.-FNRS (Belgian Fund for Scientific Research). CB, OB, J-YR, IB & CC are shareholders of SarQoL sprl. J-YR is the president of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), which has endorsed the SarQoL® questionnaire. CC reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. All other authors have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials. |
| ORCID | 0000-0002-1669-0224 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0216065 |
| PMID | 31034498 |
| PQID | 2217092960 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_2217092960 doaj_primary_oai_doaj_org_article_1ac1cc36ef8c46c4a8360c8c033976d8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6488089 liege_orbi_v2_oai_orbi_ulg_ac_be_2268_234925 proquest_miscellaneous_2217483651 proquest_journals_2217092960 gale_infotracmisc_A583952660 gale_infotracacademiconefile_A583952660 pubmed_primary_31034498 crossref_citationtrail_10_1371_journal_pone_0216065 crossref_primary_10_1371_journal_pone_0216065 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-04-29 |
| PublicationDateYYYYMMDD | 2019-04-29 |
| PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-29 day: 29 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2019 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | C Beaudart (ref7) 2017 JM Bland (ref19) 1986; 327 GA Ildiko (ref11) 2017; 12 DL Hart (ref25) 2003; 33 C Beaudart (ref10) 2017; 46 T Juul (ref28) 2016; 79 C Beaudart (ref8) 2015; 44 C Beaudart (ref9) 2017; 8 M Tsekoura (ref14) 2018 A Cruz-Jentoft (ref1) 2018 C Terwee (ref16) 2007; 60 O Ethgen (ref5) 2017 J Konstantynowicz (ref13) 2018; 7 J Dawson (ref29) 2014; 67 A Geerinck (ref12) 2018; 18 LM Harvill (ref17) 1991; 10 C Beaudart (ref4) 2018; 30 C Beaudart (ref6) 2017; 12 D. Polit (ref20) 2014; 23 ref22 IS Oliveira (ref27) 2014; 18 J.M. Bland (ref21) 1999; 2802 H Michalkova (ref23) 2017 G Shafiee (ref3) 2017; 16 RC Lee (ref24) 2000; 72 JY Reginster (ref15) 2016; 28 L Busija (ref30) 2008; 6 HCW De Vet (ref18) 2011 AJ Cruz-Jentoft (ref2) 2014; 43 S Palmer (ref26) 2017; 32 |
| References_xml | – volume: 7 start-page: 323 year: 2018 ident: ref13 article-title: Polish Validation of the SarQoL, a Quality of Life Questionnaire Specific to Sarcopenia publication-title: J Clin Med doi: 10.3390/jcm7100323 – volume: 12 start-page: e0169548 year: 2017 ident: ref6 article-title: Health outcomes of sarcopenia: a systematic seview and meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0169548 – volume: 32 start-page: 64 year: 2017 ident: ref26 article-title: Test-retest reliability and smallest detectable change of the Bristol Impact of Hypermobility (BIoH) questionnaire publication-title: Musculoskelet Sci Pract doi: 10.1016/j.msksp.2017.08.007 – volume: 67 start-page: 697 year: 2014 ident: ref29 article-title: Minimally important change was estimated for the Manchester-Oxford Foot Questionnaire after foot/ankle surgery publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2014.01.003 – volume: 72 start-page: 796 year: 2000 ident: ref24 article-title: Total-body skeletal muscle mass: Development and cross-validation of anthropometric prediction models publication-title: Am J Clin Nutr doi: 10.1093/ajcn/72.3.796 – start-page: 1 year: 2018 ident: ref1 article-title: Sarcopenia: revised European consensus on definition and diagnosis publication-title: Age Ageing – volume: 60 start-page: 34 year: 2007 ident: ref16 article-title: Quality criteria were proposed for measurement properties of health status questionnaires publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2006.03.012 – ident: ref22 – start-page: 1 year: 2018 ident: ref14 article-title: Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire publication-title: Disabil Rehabil doi: 10.1080/09638288.2018.1514076 – volume: 30 start-page: 307 year: 2018 ident: ref4 article-title: Quality of life in sarcopenia measured with the SarQoL: impact of the use of different diagnosis definitions publication-title: Aging Clin Exp Res doi: 10.1007/s40520-017-0866-9 – volume: 28 start-page: 47 year: 2016 ident: ref15 article-title: Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia publication-title: Aging Clin Exp Res doi: 10.1007/s40520-015-0517-y – start-page: 229 year: 2017 ident: ref5 article-title: The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action publication-title: Calcif Tissue Int doi: 10.1007/s00223-016-0220-9 – start-page: s104 year: 2017 ident: ref23 article-title: Health-related quality of life in sarcopenia: translation and validation of the Czech version of the SarQoL instrument publication-title: European Geriatric Medicine – volume: 10 start-page: 33 year: 1991 ident: ref17 article-title: Standard Error of Measurement publication-title: Educ Meas Issues Pract doi: 10.1111/j.1745-3992.1991.tb00195.x – volume: 46 start-page: 271 year: 2017 ident: ref10 article-title: English translation and validation of the SarQoL, a quality of life questionnaire specific for sarcopenia publication-title: Age Ageing – volume: 327 start-page: 307 year: 1986 ident: ref19 article-title: Statistical Methods for Assessing Agreement Between Two Methods of Clinical Measurement publication-title: Lancet doi: 10.1016/S0140-6736(86)90837-8 – volume: 18 start-page: 463 year: 2018 ident: ref12 article-title: Translation and validation of the Dutch SarQoL, a quality of life questionnaire specific to sarcopenia publication-title: J Musculoskelet Neuronal Interact – volume: 43 start-page: 48 year: 2014 ident: ref2 article-title: Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) publication-title: Age Ageing – volume: 44 start-page: 960 year: 2015 ident: ref8 article-title: Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL publication-title: Age Ageing. England doi: 10.1093/ageing/afv133 – year: 2011 ident: ref18 article-title: Measurements in Medicine doi: 10.1017/CBO9780511996214 – volume: 79 start-page: 31 year: 2016 ident: ref28 article-title: Psychometric properties of the Neck OutcOme Score, Neck Disability Index, and Short Form–36 were evaluated in patients with neck pain publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2016.03.015 – volume: 23 start-page: 1713 year: 2014 ident: ref20 article-title: Getting serious about test-retest reliability: A critique of retest research and some recommendations publication-title: Qual Life Res doi: 10.1007/s11136-014-0632-9 – volume: 16 start-page: 21 year: 2017 ident: ref3 article-title: Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies publication-title: J Diabetes Metab Disord. Journal of Diabetes & Metabolic Disorders doi: 10.1186/s40200-017-0302-x – volume: 8 start-page: 238 year: 2017 ident: ref9 article-title: Validation of the SarQoL, a specific health-related quality of life questionnaire for Sarcopenia publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.12149 – volume: 6 start-page: 1 year: 2008 ident: ref30 article-title: Magnitude and meaningfulness of change in SF-36 scores in four types of orthopedic surgery publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-6-55 – volume: 2802 start-page: 135 year: 1999 ident: ref21 article-title: Measuring agreement in method comparison studies publication-title: Stat. Meth – start-page: 1 year: 2017 ident: ref7 article-title: Quality of life assessment in musculo-skeletal health publication-title: Aging Clin Exp Res – volume: 18 start-page: 372 year: 2014 ident: ref27 article-title: Assessment of the measurement properties of quality of life questionnaires in Brazilian women with breast cancer publication-title: Brazilian J Phys Ther doi: 10.1590/bjpt-rbf.2014.0045 – volume: 12 start-page: 103 year: 2017 ident: ref11 article-title: Psychometric performance of the Romanian version of the SarQoL, a health-related quality of life questionnaire for sarcopenia publication-title: Arch Osteoporos. Archives of Osteoporosis doi: 10.1007/s11657-017-0397-1 – volume: 33 start-page: 734 year: 2003 ident: ref25 article-title: Test-Retest Reliability of an Abbreviated Self-Report Overall Health Status Measure publication-title: J Orthop Sport Phys Ther doi: 10.2519/jospt.2003.33.12.734 |
| RestrictionsOnAccess | open access |
| SSID | ssj0053866 |
| Score | 2.4968314 |
| Snippet | The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55 items. It... Objectives The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55... Objectives The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient- reported outcome measure, evaluates quality of life with 55... ObjectivesThe Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55... Objectives The Sarcopenia Quality of Life (SarQoL) questionnaire, a sarcopenia-specific patient-reported outcome measure, evaluates quality of life with 55... |
| SourceID | plos doaj pubmedcentral liege proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0216065 |
| SubjectTerms | Aged Aged, 80 and over Aging Analysis Biology and Life Sciences Bone surgery Change detection Epidemiology Error analysis Error detection Female Fractures Geriatrics Gerontology Health economics Hospitals Human health sciences Humans Male Mathematical analysis Medical research Medicine Medicine and Health Sciences Middle Aged Mortality Musculoskeletal system People and places Public health Public health, health care sciences & services Quality of Life Quantitative psychology Research and Analysis Methods Santé publique, services médicaux & soins de santé Sarcopenia Sarcopenia - pathology Sciences de la santé humaine Social Sciences Standard error Standard error of measurement Surveys and Questionnaires Systematic errors Systematic review Validation studies Womens health Working groups |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEG4kXryI8ZXRKC0IJuAk8-jpmfG2iiFIECQGcmv6iQObmbCzK_iP_JlWdfeOGQnk4m3Zqt1-VHVV9aO-IuStNE3BpGIpy7GEmeNF2rqmSovc1oZzJo3yr3y_8tML9uWyurxR6gvfhAV44DBxx7nUudYlt67RjGsmMetANzor0ZMan-YLPm-7mQo2GFYx5zFRrqzz4yiXo-uht0fg1SBqr2aOyOP1T1b5_hIvrBHudDmMt4We_76gvOGSTh6RhzGWpIswhl1yz_aPyW5crSM9iJDSh0_I7_N4YkDtajWs6ODo1d_DQQo0Ol5hVZVxTY3FewXMqKIhKxi5IUyk57AmsNhWJ2lA3viFlLPOWXoAtG_D2SH1AwBR9xJM6Qe66OG_A-oJ8o4bhcc-I8WkFtpS0PIu1HSiY3jP-JRcnHz-_uk0jTUaUg22Yp1ylimea146qZSWyinb1ka1xjnw_IWWrlIQYTjWGG6kzmrOK-daCRszWclalc_ITg9S2SOU18Y0UtnGZYa1oCaVQjzApnXaQuCUJ6TcCkzoCGCOdTSWwt_K1bCRCfMuUMwiijkh6fSr6wDgcQf_R9SFiRfht_0XoJQiKqW4SykT8g41SaCRgC5qGXMdoB2E2xKLCuLSCmKjLCH7M05Y3HpGfu91EVpXnfhZ-O74z5sldEcLZQUE0I0oPMpkQvZQZbcDG4GW1xlEwL6hrRrfTn4zkbEP-PSut8Mm8DAYXwUCeB60fpocLFLHWAvjrWfrYTZ7c0rf_fAg5hw9R9O--B_T_ZI8gDjWX_IV7T7ZWa829hXEimv12puFP69tbAc priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1taxQxEA7agggi9nzpaZUIgi247b5ks7t-kVMsRaogtdBvIa96cN09b-8E_5E_05kkt_Wk6LfjJnebbGYmTzKZZwh5IU2dM6lYwjIsYeZ4njSuLpM8s5XhnEmj_C3fT_zknH24KC_igVsfr1WufaJ31KbTeEZ-lAN2TmEt5-mb-fcEq0ZhdDWW0LhJtpG6DK90VRfDhgtsmfOYLldU2VGcncN519pDWNsAu5cby5Fn7R988_YMw9ZIejrr-usA6N_3KP9YmI7vkbsRUdJJUIEdcsO2I3LrY4yZj8idcDJHQ8LRiOxEc-7pfuScPrhPfp3FIwVqF4tuQTtHL69ODynIaH-JZVf6JTUWAw-YckVD2jC2BhxJz8BosBrXVNJAzfETJadTZ-k-yD53pwfUjw10oZXga1_TSQv_HWhRsG2_Ungu1FPMeqENBTOYhqJPtA8XHh-Q8-P3X96dJLGIQ6LBmSwTzlLFM80LJ5XSUjllm8qoxjgH0CDX0pUKIIhjteFG6rTivHSukbBzk6WsVPGQbLUwYbuE8sqYWipbu9SwBvSoVEgYWDdOW0BW2ZgU67kUOjKcY6GNmfBhuwp2OmFKBGqAiBowJsnwq3lg-PhP-7eoJkNb5Of2X3SLryKau8ikzrQuuHW1ZlwzibkyutZpgfjP1GPyEpVMoBeBLmoZkyHgOcjHJSYlANcSwFM6JnsbLcH69Yb4lVdTeLqaih-5747_vJpBd7RQVgDCrkXuaSjHZBe1eT2wXlyZFTxoreHXi58PYuwD3s1rbbcKbRiMr4QJeBQMYng5WMWOsQbGW22Yysbb25S002-e5Zzj0lI3j__drSfkNkBYH9_Lmz2ytVys7FOAiUv1zPuC321Sa5Q priority: 102 providerName: ProQuest |
| Title | Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31034498 https://www.proquest.com/docview/2217092960 https://www.proquest.com/docview/2217483651 http://orbi.ulg.ac.be/handle/2268/234925 https://pubmed.ncbi.nlm.nih.gov/PMC6488089 https://doaj.org/article/1ac1cc36ef8c46c4a8360c8c033976d8 http://dx.doi.org/10.1371/journal.pone.0216065 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1tb9MwELa2VUL7ghhvC4zKSEhsEqma1HEcJIS6aWVCYwJGpX6LbMeGSl0ykhaxf8TP5M5JCkGd-BJVvUv8dmc_fnuOkBcyEyGTivkswBBmlod-YkXkh4GJM86ZzJQ75XvBz6bs_SyabZE2ZmtTgdXGqR3Gk5qWi8HP7zdvweHfuKgNcdC-NLgucjOAMQswebRNejA2xeiqH9h6XwG8m_PmAt1tb-6SOxh7i7FEdMYqR-m_7rh7C9zTRkbURVFtQqf_HrL8a9Sa3CN3G7hJx7V97JEtk98ne41DV_SwYZ0-ekB-XTaLCtSUZVHSwtKrP-uHFGS0usLAK9WSZga3HvDSFa0vDqM2IEl6CW6D9TeXtCbnuEHJ-dwaegiyT8X5EXUFAGvIJfS2r-k4h2_XxCioW60UrgxVFO-90ISCI8zrsE-0qo88PiTTyemXkzO_CePga-hOlj5nQ8UDzUdWKqWlssokcaaSzFoAB6GWNlIAQiwTGc-kHsacR9YmEuZuMpKxGj0iOzk00D6hPM4yIZURdpixBCwpUkgZKBKrDWCrwCOjtsFS3XCcY6iNReo27mKY69T1nmKLp02Le8Rfv3Vdc3z8R_8YbWGtiwzd7o-i_Jo2Dp8GUgdaj7ixQjOumcTbMlro4QgRYCY88hItKUXLhixq2VyHgHSQkSsdRwBdI4BPQ48cdDTB_3VH_MrZIqSu5umP0GXH_V4tIDs6VSYFjC3S0BFRemQfTbYtWAWyIB4CSHYJtWa8Wfx8LcY84Om83BSrWodB-SJogMe11a8rp_Ulj8Qdf-jUXleSz785nnOOg4tIntz6zadkF_Cr29wLkwOysyxX5hlgxKXqk-14FsNTnAT4nLzrk97x6cXHz3236tJ33cJv0sduNQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rT9RAEN8gJGpijOCDU9Q10QgJhba33bYmxuCDgBwkBkj4tu5TLzlavN5p-I_85N_ozG7v8AzRT3y73Ey7u53fzsw-ZoaQ59IUKZOKRSzBEmaOp1HpiixKE5sbzpk0yt_yPeA7x-zjSXYyR35NYmHwWuVEJ3pFbWqNe-SbKfjOMdhyHr85-xZh1Sg8XZ2U0Aiw2LPnP2DJ1rzefQ_yfZGm2x-O3u1EbVWBSAO6RxFnseKJ5l0nldJSOWXL3KjSOAe2KtXSZQpsomOF4UZqWOfzzLlSwlJCZjJXXXjvNbIAhjfGGZWfTBd4oDs4b8Pzunmy2aJh46yu7AbYUlgrZDPmz1cJmNqChQEek2OS1UHdXObw_n1v8w9DuH2H3G49WLoVILdI5my1RK7vt2f0S-RW2AmkIcBpiSy26qOhq22O67W75Odhu4VB7XBYD2nt6OnFbiUFGm1OscxLM6LG4kEHhnjREKaM3OC30kOQBlb_6ksaUoGcI6XXd5auAu1T3VujfmyAvUqCbn9Ftyp4d0jDgrzNWOE-VEMxyoaWFKZdPxSZok24YHmPHF-JeO-T-QoEtkwoz40ppLKFiw0rAbeZwgSFRem0BU8u6ZDuRJZCtxnVsbDHQPhjwhxWVkEkAhEgWgR0SDR96ixkFPkP_1uEyZQX84H7P-rhF9GqF5FInWjd5dYVmnHNJMbm6ELHXfQ3TdEhLxFkArUWdFHLNvgC2sH8X2IrA0c5A2ct7pCVGU7QNnqGvO5hCq2rvvie-u743-MBdEcLZQV49IVIfdrLDllGNE8G1oiLaQwNTRB-OfnZlIx9wLuAla3HgYfB-DIQwIMwIaYfB6vmMVbCePOZqTLz9WYpVf-rz6rO0ZQV5cN_d-spubFztN8Tvd2DvUfkJrjP_mwxLVfI_Gg4to_BRR2pJ14vUPL5qhXRb-qsqyE |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tTxQxEG4QEmJijOALp6g10QiJC7e73e6uiTEoEhAkGiC5b7Wvesmxi7d3Gv6Rv8Ff50y7d3iG6Ce-XW6623bn6by0nRlCnkpTJEwqFrEYS5g5nkSlK7IoiW1uOGfSKH_L95DvnrD3vaw3R35NYmHwWuVEJnpBbWqNe-SbCdjOXdDlvLvp2msRH7d3Xp99i7CCFJ60TsppBIjs2_Mf4L41r_a2gdfPkmTn3fHb3aitMBBpQPoo4qyreKx56qRSWiqnbJkbVRrnQG8lWrpMgX50rDDcSA0-P8-cKyW4FTKTuUrhvdfIQp5mMa6xvDd19kCOcN6G6qV5vNkiY-OsruwG6FXwG7IZVegrBkz1wsIAj8wx4eqgbi4zfv--w_mHUty5RW621izdCvBbInO2WiaLH9rz-mVyI-wK0hDstEyWWlHS0LU23_X6bfLzqN3OoHY4rIe0dvT0YueSAo02p1jypRlRY_HQA8O9aAhZxtZgw9Ij4AZWAutLGtKCnCPloO8sXQPap_pgnfq5AQ4rCXL-Jd2q4N0hJQu2bcYK96QaihE3tKSwBPuh4BRtwmXLO-TkSth7l8xXwLAVQnluTCGVLVzXsBIwnClMVliUTluw6uIOSSe8FLrNro5FPgbCHxnm4GUFlghEgGgR0CHR9KmzkF3kP-3fIEymbTE3uP-jHn4RragRsdSx1im3rtCMayYxTkcXupui7WmKDnmOIBMowWCIWraBGNAP5gITWxkYzRkYbt0OWZ1pCZJHz5BfeJhC76ovvid-OP73eADD0UJZAdZ9IRKfArNDVhDNk4k14mJJQ0cThF9OfjIl4xjwXmBl63Fow2B-GTDgXlgQ04-DFfQYK2G--cxSmfl6s5Sq_9VnWOeo1ory_r-H9ZgsgggSB3uH-w_IdbCk_TFjUq6S-dFwbB-CtTpSj7xYoOTzVcuh36iIr1c |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Standard+error+of+measurement+and+smallest+detectable+change+of+the+Sarcopenia+Quality+of+Life+%28SarQoL%29+questionnaire%3A+An+analysis+of+subjects+from+9+validation+studies&rft.jtitle=PloS+one&rft.au=Geerinck%2C+Anton&rft.au=Alekna%2C+Vidmantas&rft.au=Beaudart%2C+Charlotte&rft.au=Bautmans%2C+Ivan&rft.date=2019-04-29&rft.eissn=1932-6203&rft.volume=14&rft.issue=4&rft.spage=e0216065&rft_id=info:doi/10.1371%2Fjournal.pone.0216065&rft_id=info%3Apmid%2F31034498&rft.externalDocID=31034498 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |